1. Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin 
Steven Fishbane, Jeffrey S. Berns, M.D. 
Kidney International 
Volume 68, Issue 3, Pages (September 2005)
DOI: /j x
Copyright © 2005 International Society of Nephrology Terms and Conditions

2. Figure 1
Distribution of the number of recombinant human erythropoietin (rHuEPO) dose changes per patient in 1 year.
Kidney International  , DOI: ( /j x)
Copyright © 2005 International Society of Nephrology Terms and Conditions

3. Figure 2
A graphic example of hemoglobin (Hgb) cycling in a 59-year-old diabetic man, showing both hemoglobin and recombinant human erythropoietin (rHuEPO) dose.
Kidney International  , DOI: ( /j x)
Copyright © 2005 International Society of Nephrology Terms and Conditions

4. Figure 3
Distribution of the number of hemoglobin excursions per patient in 1 year.
Kidney International  , DOI: ( /j x)
Copyright © 2005 International Society of Nephrology Terms and Conditions

5. Figure 4
Distribution of hemoglobin (Hgb) amplitude for all hemoglobin excursions. The amplitude is the difference between hemoglobin level at the beginning and end of an excursion.
Kidney International  , DOI: ( /j x)
Copyright © 2005 International Society of Nephrology Terms and Conditions